Gu; Zhengxiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gu; Zhengxiang.The latest application filed is for "method, a system, a device and a readable medium for setting access permission for an application".

Company Profile

3.19.19

Gu; Zhengxiang - Shanghai CN
GU; Zhengxiang - ShanghaiI CN
Gu; Zhengxiang - Piscataway NJ
Gu; Zhengxiang - Princeton NJ US
Gu; Zhengxiang - Plainsboro NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method and device method and device for obtaining access information of shared wireless access point Grant 10,880,823 - Gu December 29, 2	2020-12-29
Method, A System, A Device And A Readable Medium For Setting Access Permission For An Application App 20200356682 - GU; Zhengxiang	2020-11-12
Method and device for handing over user equipment among wireless access points Grant 10,728,813 - Gu	2020-07-28
Method and device for establishing wireless connection Grant 10,716,151 - Li , et al.	2020-07-14
Running exercise equipment with associated virtual reality interaction method and non-volatile storage media Grant 10,445,932 - Chen , et al. Oc	2019-10-15
Method and device for establishing wireless connection Grant 10,299,191 - Gu	2019-05-21
Method And Device For Handing Over User Equipment Among Wireless Access Points App 20180376395 - GU; Zhengxiang	2018-12-27
Method And Device For Establishing Wireless Connection App 20180376523 - LI; Haiyang ; et al.	2018-12-27
Method And Device Method And Device For Obtaining Access Information Of Shared Wireless Access Point App 20180343609 - GU; Zhengxiang	2018-11-29
Method And Device For Establishing Wireless Connection App 20180343606 - GU; Zhengxiang	2018-11-29
Running Exercise Equipment With Associated Virtual Reality Interaction Method And Non-volatile Storage Media App 20180053349 - CHEN; Danian ; et al.	2018-02-22
Dihydropyrazole GPR40 modulators Grant 9,604,964 - Ellsworth , et al. March 28, 2	2017-03-28
Dihydropyrazole Gpr40 Modulators App 20160297797 - Ellsworth; Bruce A. ; et al.	2016-10-13
Substituted adipic acid amides and uses thereof Grant 9,346,852 - Sun , et al. May 24, 2	2016-05-24
Substituted Adipic Acid Amides And Uses Thereof App 20130345123 - Sun; Chongqing ; et al.	2013-12-26
Tetrahydroquinoline derivatives as cannabinoid receptor modulators Grant 8,119,808 - Sun , et al. February 21, 2	2012-02-21
Tetrahydroquinoline Derivatives As Cannabinoid Receptor Modulators App 20110104315 - Sun; Chongqing ; et al.	2011-05-05
Tetrahydroquinoline derivatives as cannabinoid receptor modulators Grant 7,884,113 - Sun , et al. February 8, 2	2011-02-08
Inhibitors of 15-lipoxygenase Grant 7,754,755 - Murugesan , et al. July 13, 2	2010-07-13
Triazolopyrimidine cannabinoid receptor 1 antagonists Grant 7,452,892 - Wu , et al. November 18, 2	2008-11-18
Tetrahydroquinoline Derivatives As Cannabinoid Receptor Modulators App 20080194625 - Sun; Chongqing ; et al.	2008-08-14
Azabicyclic heterocycles as cannabinoid receptor modulators Grant 7,378,418 - Yu , et al. May 27, 2	2008-05-27
Dihydropyrimidone inhibitors of calcium channel function Grant 7,166,603 - Murugesan , et al. January 23, 2	2007-01-23
Substituted dihydropyrimidine inhibitors of calcium channel function Grant 7,157,461 - Murugesan , et al. January 2, 2	2007-01-02
Triazolopyrimidine cannabinoid receptor 1 antagonists App 20060287341 - Wu; Gang ; et al.	2006-12-21
Inhibitors of 15-lipoxygenase App 20060063823 - Murugesan; Natesan ; et al.	2006-03-23
Azabicyclic heterocycles as cannabinoid receptor modulators App 20050143381 - Yu, Guixue ; et al.	2005-06-30
Dihydropyrimidone inhibitors of calcium channel function App 20050043339 - Murugesan, Natesan ; et al.	2005-02-24
Substituted dihydropyrimidine inhibitors of calcium channel function App 20050043322 - Murugesan, Natesan ; et al.	2005-02-24
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists Grant 6,852,745 - Murugesan , et al. February 8, 2	2005-02-08
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists Grant 6,835,741 - Murugesan , et al. December 28, 2	2004-12-28
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists App 20040127515 - Murugesan, Natesan ; et al.	2004-07-01
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists App 20040106833 - San, Natesan Murug ; et al.	2004-06-03
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists Grant 6,638,937 - Murugesan , et al. October 28, 2	2003-10-28
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists App 20020143024 - Murugesan, Natesan ; et al.	2002-10-03
Isoxazolyl endothelin antagonists Grant 6,043,265 - Murugesan , et al. March 28, 2	2000-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.